QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fourth of one Redeemable Warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||||
Item 1. |
FINANCIAL STATEMENTS (UNAUDITED) | |||||
Condensed Balance Sheets | 1 | |||||
Condensed Statements of Operations | 2 | |||||
Condensed Statements of Changes in Stockholders’ Equity (Deficit) | 3 | |||||
Condensed Statements of Cash Flows | 4 | |||||
Notes to Condensed Financial Statements | 5 | |||||
Item 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 22 | ||||
Item 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 25 | ||||
Item 4. |
CONTROLS AND PROCEDURES | 25 | ||||
Item 1. |
LEGAL PROCEEDINGS | 26 | ||||
Item 1A. |
RISK FACTORS | 26 | ||||
Item 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 27 | ||||
Item 3. |
DEFAULTS UPON SENIOR SECURITIES | 27 | ||||
Item 4. |
MINE SAFETY DISCLOSURES | 27 | ||||
Item 5. |
OTHER INFORMATION | 27 | ||||
Item 6. |
EXHIBITS | 27 | ||||
28 |
September 30, 2021 |
December 31, 2020 |
||||||||
(Unaudited) | |||||||||
ASSETS |
|||||||||
Current assets: |
|||||||||
Cash |
$ | $ | |||||||
Prepaid expenses |
— | ||||||||
Total current assets |
|||||||||
Deferred offering costs |
— | ||||||||
Investments held in Trust Account |
— | ||||||||
Total Assets |
$ |
$ |
|||||||
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
|||||||||
Current liabilities: |
|||||||||
Accrued expenses |
$ | $ | — | ||||||
Franchise tax payable |
— | ||||||||
Sponsor note |
— | ||||||||
Total current liabilities |
|||||||||
Warrant liabilities |
— | ||||||||
Deferred underwriting fee payable |
— | ||||||||
Total Liabilities |
|||||||||
Commitments (see Note 7) |
|||||||||
Class A common stock, subject to possible redemption; September 30, 2021 and December 31, 2020, respectively |
— | ||||||||
Stockholders’ (Deficit) Equity: |
|||||||||
Preferred stock, $ 2021 and December 31, 2020, respectively |
|||||||||
Class A common stock, $ shares subject to possible redemption) at September 30, 2021 and December 31, 2020 |
— | ||||||||
Class B authorized; (1) and (2) shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively |
|||||||||
Additional paid-in capital |
— | ||||||||
Accumulated deficit |
( |
) | — | ||||||
Total Stockholders’ (Deficit) Equity |
( |
) | |||||||
Total Liabilities and Stockholders’ (Deficit) Equity |
$ |
$ |
|||||||
(1) | Excludes 4 ). |
(2) | Includes an aggregate of up to |
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period from July 6, 2020 (inception) Through September 30, 2020 |
||||||||||
Operating and formation costs |
$ | $ | $ | |||||||||
Franchise tax expense |
— | |||||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | — | |||||||
Transaction costs allocated to warrant liabilities |
— | ( |
) | — | ||||||||
Net gain on investments held in Trust Account |
— | |||||||||||
Excess of private placement warrant fair value over purchase price |
— | ( |
) | — | ||||||||
Change in fair value of warrant liabilities |
— | |||||||||||
|
|
|
|
|
|
|||||||
Net income |
$ | $ | $ | — | ||||||||
|
|
|
|
|
|
|||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
— | |||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income per share, Class A common stock |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Basic and diluted weighted average shares outstanding Class B common stock |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income per share, Class B common stock |
$ | $ | $ |
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance, December 31, 2020 (1) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Forfeiture of Class B common stock |
( |
) | ( |
) | — | — | ||||||||||||||||||||||
Accretion of Class A common stock to redemption amount (Restated - see Note 2) |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance, March 31, 2021 (Restated - see Note 2) |
— | ( |
) | ( |
) | |||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance, June 30, 2021 (Restated - see Note 2) |
— | — | — | ( |
) | ( |
) | |||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance, September 30, 2021 |
— | $ | — | $ | $ | — | $ | ( |
) | $ | ( |
) | ||||||||||||||||
(1) | Includes an aggregate of up to held by the sponsor that were subject to forfeiture to the extent that the underwriter’s over-allotment was not exercised in full, |
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B (1) |
Additional Paid-in Capital |
Accumulated Earnings |
Total Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance, July 6, 2020 (inception) |
$ | |||||||||||||||||||||||||||
Sale of Class B common stock to Sponsor |
— | — | — | |||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | ||||||||||||||||||||||
Balance, September 30, 2020 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
(1) | Includes an aggregate of up to shares held by the sponsor that were subject to forfeiture to the extent that the underwriter’s over-allotment was not exercised in full, |
Nine Months Ended September 30, 2021 |
For the Period from July 6, 2020 (inception) Through September 30, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | $ | — | |||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Transaction costs allocated to warrant liabilities |
— | |||||||
Net gain on investments held in Trust Account |
( |
) | — | |||||
Excess of private placement warrant fair value over purchase price |
— | |||||||
Change in fair value of warrant liabilities |
( |
) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | — | |||||
Accrued Expenses |
— | |||||||
Franchise tax payable |
— | |||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited into Trust Account |
( |
) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | — | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from initial public offering, net of underwriter’s discount paid |
||||||||
Proceeds from sale of Class B common stock to Sponsor |
||||||||
Proceeds from Sponsor note |
||||||||
Repayment of Sponsor note |
( |
) | — | |||||
Proceeds from sale of private placement warrants |
— | |||||||
Payment of offering costs |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Increase in cash |
||||||||
Cash at beginning of period |
— | |||||||
|
|
|
|
|||||
Cash at end of period |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Deferred underwriting fee payable |
$ | $ | — | |||||
|
|
|
|
|||||
Initial classification of warrant liabilities |
$ | $ | — | |||||
|
|
|
|
|||||
Accretion of Class A common stock subject to redemption to redemption value |
$ | $ | — | |||||
|
|
|
|
|||||
Reclassification of deferred offering costs to equity upon completion of the initial public offering |
$ | $ | — | |||||
|
|
|
|
June 30, 2021 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Condensed Balance Sheet (unaudited) |
||||||||||||
Class A common stock subject to possible redemption; |
$ | $ | $ | |||||||||
Class A common stock; |
$ | $ | ( |
) | $ | — | ||||||
Retained earnings (accumulated deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Total stockholders’ equity (deficit) |
$ | $ | ( |
) | $ | ) | ||||||
Condensed Statement of Operations for the Three Months Ended June 30, 2021 (unaudited) |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||||||||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
$ |
|||||||||
Basic and diluted weighted average shares outstanding, Class B common stock (1) |
( |
) |
||||||||||
Basic and diluted net income per share, Class B common stock |
$ |
$ |
( |
) |
$ |
|||||||
Condensed Statement of Operations for the Six Months Ended June 30, 2021 (unaudited) |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
( |
) |
||||||||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
$ |
|||||||||
Basic and diluted weighted average shares outstanding, Class B common stock (1) |
( |
) |
||||||||||
Basic and diluted net income per share, Class B common stock |
$ |
$ |
( |
) |
$ |
|||||||
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited) |
||||||||||||
Class A common stock subject to possible redemption |
$ |
( |
) |
$ |
$ |
|||||||
Condensed Statement of Cash Flows for the Six Months Ended June 30, 2021 (unaudited) - Supplemental disclosure of non-cash investing and financing activities |
||||||||||||
Class A common stock subject to possible redemption |
$ |
$ |
( |
) |
$ |
|||||||
Accretion of Class A common stock to redemption amount |
(1) |
Prior to the change in presentation for the Class A common stock subject to possible redemption, the Company applied to two class method of earnings per share, allocating net income between redeemable Class A common stock and non-redeemable Class A and Class B common stock. As such, a portion of the Class A common stock was included in the weighted average shares outstanding of Class B common stock in the As Previously Reported balances. |
March 31, 2021 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Condensed Balance Sheet (unaudited) |
||||||||||||
Accrued expenses |
||||||||||||
Class A common stock subject to possible redemption; |
$ | $ | $ | |||||||||
Class A common stock; |
$ | $ | ( |
) | $ | — | ||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | — | ||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total stockholders’ equity (deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Condensed Statement of Operations for the Three Months Ended March 31, 2021 (unaudited) |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
( |
) |
||||||||||
Basic and diluted net loss per share, Class A common stock |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Basic and diluted weighted average shares outstanding, Class B common stock (1) |
( |
) |
||||||||||
Basic and diluted net loss per share, Class B common stock |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited) |
||||||||||||
Sale of |
( |
) |
||||||||||
Class A common stock subject to possible redemption |
( |
) |
||||||||||
Accretion of Class A common stock to redemption amount |
( |
) |
( |
) | ||||||||
Condensed Statement of Cash Flows for the Three Months Ended March 31, 2021 (unaudited) - Supplemental disclosure of non-cash investing and financing activities |
||||||||||||
Class A common stock subject to possible redemption |
( |
) |
||||||||||
Accretion of Class A common stock to redemption amount |
(1) |
Prior to the change in presentation for the Class A common stock subject to possible redemption, the Company applied to two class method of earnings per share, allocating net income between redeemable Class A common stock and non-redeemable Class A and Class B common stock. As such, a portion of the Class A common stock was included in the weighted average shares outstanding of Class B common stock in the As Previously Reported balances. |
March 4, 2021 |
||||||||||||
As Previously Reported |
Adjustments |
As Re stated |
||||||||||
Balance Sheet (audited) |
||||||||||||
Class A common stock subject to possible redemption; |
$ |
$ |
$ |
|||||||||
Class A common stock; |
$ |
$ |
( |
) |
$ |
— |
||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
— |
||||||
Accumulated deficit |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Total stockholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) |
Gross proceeds |
$ |
|||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Issuance costs allocated to Class A common stock |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A common stock subject to possible redemption |
$ |
|||
|
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period from July 6, 2020 (inception) Through September 30, 2020 |
||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||
Basic and diluted net income per share: |
||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||
Net income |
$ | $ | $ | |
$ | |
$ | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Denominator: |
||||||||||||||||||||||||
Basic and diluted weighted average shares outstanding |
|
|
— | |||||||||||||||||||||
Basic and diluted net income per share |
$ | $ | $ | |
$ | |
$ | $ |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than “30-day redemption period”) to each warrant holder; and |
• | if, and only if, the reported last sale price of the Class A common stock equals or exceeds $ |
Description |
Amount at Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
September 30, 2021 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
Money Market investments |
$ | $ | $ | — | $ | — | ||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | — | $ | — | ||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | — | $ | — | $ | ||||||||||
December 31, 2020 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
Money Market investments |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | $ | ||||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | $ | $ |
As of March 4, 2021 |
||||
Stock Price on Valuation Date |
$ | |||
Strike price (Exercise Price Share) |
$ | |||
Probability of completing a Business Combination |
% | |||
Term (in years) |
||||
Volatility |
||||
Risk-free rate |
% | |||
Fair value of warrants |
$ |
As of March 4, 2021 |
As 2021 |
|||||||
Stock price |
$ | $ | ||||||
Strike price |
$ | $ | ||||||
Probability of completing a Business Combination |
% | * | ||||||
Dividend yield |
% | % | ||||||
Term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Fair value of warrants |
$ | $ |
* |
The probability of completing a Business Combination is considered within the volatility implied by the traded price of the Public Warrants which is used to value the Private Placement Warrants. |
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of September 30, 2020 |
$ | — | $ | — | $ | — | ||||||
Initial measurement as of March 4, 2021 |
||||||||||||
Additional warrants issued in over-allotment |
||||||||||||
Change in valuation inputs or other assumptions |
( |
) |
( |
) |
( |
) | ||||||
|
|
|
|
|
|
|||||||
Fair value as of September 30, 2021 |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
* | Filed herewith. |
** | Furnished. |
Haymaker Acquisition Corp. III | ||||||
Date: November 29, 2021 | By: | /s/ Steven J. Heyer | ||||
Name: Steven J. Heyer | ||||||
Title: Chief Executive Officer |